Swietokrzyskie Centrum Onkologii

Kielce, Świętokrzyskie Voivodeship 25-734

1 studies enrolling now · 2 studies all time

What they study most

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndrome, Smoldering Multiple Myeloma (SMM)

Studies at this site

• A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma — Recruiting now
• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed